Back to All Events

Psychopharmacologic Drugs Advisory Committee

The committee will discuss new drug application (NDA) 209500, lumateperone tosylate capsules for oral administration, submitted by Intra-Cellular Therapies, Inc., for the treatment of schizophrenia.

Earlier Event: July 25
Arthritis Advisory Committee